Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors - Related Studies

Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00003269. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Breast Cancer
		Cancer-Related Problem/Condition
		Lung Cancer
		Lymphoma
		Ovarian Cancer

2	Additional conditions recognized in this trial
		Breast Neoplasms
		Lung Neoplasms
		Lymphoma, Large-Cell, Immunoblastic
		Lymphoma, Non-Hodgkin
		Ovarian Neoplasms

3	More general conditions related to this trial
		Adnexal Diseases
		Breast Diseases
		Endocrine Gland Neoplasms
		Endocrine System Diseases
		Genital Diseases, Female
		Genital Neoplasms, Female
		Gonadal Disorders
		Immune System Diseases
		Immunoproliferative Disorders
		Lung Diseases
		Lymphatic Diseases
		Lymphoproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Ovarian Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Skin Diseases
		Thoracic Neoplasms
		Urogenital Neoplasms

4	Interventions listed in this trial
		amifostine trihydrate
		cisplatin
		cyclophosphamide
		etoposide
		sargramostim

5	Additional drug interventions recognized in this trial
		Amifostine

6	More general drug interventions related to this trial
		Alkylating Agents
		Antineoplastic Agents
		Antineoplastic Agents, Alkylating
		Antineoplastic Agents, Phytogenic
		Antirheumatic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Myeloablative Agonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Protective Agents
		Radiation-Protective Agents
		Radiation-Sensitizing Agents
		Therapeutic Uses

7	Sponsors listed in this trial
		Ida M. and Cecil H. Green Cancer Center at Scripps Clinic